Search

Your search keyword '"Calvo Alen, Jaime"' showing total 133 results

Search Constraints

Start Over You searched for: Author "Calvo Alen, Jaime" Remove constraint Author: "Calvo Alen, Jaime"
133 results on '"Calvo Alen, Jaime"'

Search Results

3. Reduction of disease activity, corticosteroids use, and healthcare resource utilisation in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: OBSErve Spain multicentre study

7. HLA association with the susceptibility to anti-synthetase syndrome

8. Development of an application for mobile phones (App) based on the collaboration between the Spanish Society of Rheumatology and Spanish Society of Family Medicine for the referral of systemic autoimmune diseases from primary care to rheumatology

10. Efficacy and safety of combined therapy with synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: Systematic literature review

11. Desarrollo de una aplicación para teléfonos móviles (app) basada en la colaboración Sociedad Española de Reumatología/Sociedad Española de Medicina de Familia y Comunitaria para derivación de enfermedades autoinmunes sistémicas

13. Eficacia y seguridad de la terapia combinada con fármacos modificadores de la enfermedad sintéticos en la artritis reumatoide: revisión sistemática de la literatura

18. Pure Membranous Lupus Nephritis: Description of a Cohort of 150 Patients and Review of the Literature

19. Lack of awareness of systemic lupus erythematosus and its consequences in a cohort of moderate and severe patients in Spain: The LupusVoice study.

20. Recommendations for the Use of Parenteral Methotrexate in Rheumatic Diseases

21. Recomendaciones sobre el uso de metrotexato parenteral en enfermedades reumáticas

22. Biologic Disease-modifying Antirheumatic Drug Attributes in the First Lines of Treatment of Rheumatoid Arthritis. 2015 ACORDAR Project

23. Atributos del fármaco antirreumático modificador de la enfermedad biológico en las primeras líneas de tratamiento de la artritis reumatoide. Proyecto ACORDAR 2015

24. LSO-089 Effectiveness of belimumab in systemic lupus erythematosus patients of a multicenter Spanish cohort

25. LP-191 Baseline profile of systemic lupus erythematosus patients on treatment with belimumab of a Spanish multicenter cohort

31. SER Consensus Statement on the Use of Biologic Therapy for Systemic Lupus Erythematosus

32. Consenso de la Sociedad Española de Reumatología sobre el uso de terapias biológicas en el lupus eritematoso sistémico

41. Infecciones graves en pacientes con terapia biológica

44. Current laboratory and clinical practices in reporting and interpreting anti-nuclear antibody indirect immunofluorescence (ANA IIF) patterns : results of an international survey

48. Secondary Hemophagocytic Syndrome: Differences between the etiologies autoimmunes and hematological malignancies subgroup

49. Apremilast in refractory orogenital ulcers and other manifestations of Behçet's disease. National multicenter study of 51 cases in clinical practice.

50. Incidence of first cardiovascular event in Spanish patients with inflammatory rheumatic diseases: prospective data from the CARMA Project

Catalog

Books, media, physical & digital resources